title: Clinical efficacy of local administration of ceftiofur in a Staphylococcus aureus infection in tissue cages in ponies.
abstract: Ceftiofur concentrations in an infected and uninfected environment were compared and the efficacy of locally administered ceftiofur was evaluated in an experimental infection with Staphylococcus aureus in tissue cages. Eight ponies had tissue cages (TCs) implanted s.c. on each side of the neck. Into one of the cages 150 mg of ceftiofur was administered and fluid samples were taken to determine ceftiofur concentrations. After 1 week the other TC was infected with S. aureus and subsequently treated with 150 mg ceftiofur administered locally into the TC once daily for 21 days. Samples of fluid were taken to determine ceftiofur concentrations and for bacterial counts. Ceftiofur concentrations did not differ significantly in the infected and uninfected environments after single dose of 150 mg of ceftiofur. Concentrations were considerably in excess of the minimum inhibitory concentration (MIC) of the S. aureus strain used. A marked decrease of viable bacteria in tissue cage fluid (TCF) occurred. In five of seven ponies; however, the infection was not eliminated and abscess formation occurred. Therefore, local application of ceftiofur alone is not advisable for infections with S. aureus in secluded sites in horses, but should be used only with adjunctive therapy.
authors.affiliation: Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. g.bosch@vet.uu.nl
authors.forename: G
authors.initials: G
authors.lastname: Bosch
authors.forename: E
authors.initials: E
authors.lastname: van Duijkeren
authors.forename: A A
authors.initials: AA
authors.lastname: Bergwerff
authors.forename: A B M
authors.initials: AB
authors.lastname: Rijkenhuizen
authors.forename: J M
authors.initials: JM
authors.lastname: Ensink
mesh_terms: D000818:Animals; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D006736:Horses; D008297:Male; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects; D017211:Treatment Failure
chemical_list: D002511:Cephalosporins; C053503:ceftiofur